Premier Inc. Statement on FDA Opioid Policy Steering Committee Last Updated: May 24, 2017
Filed under:
Print Friendly, PDF & Email

By Blair Childs, Premier, Senior Vice President of Public Affairs 

Premier commends FDA Commissioner Scott Gottlieb for launching an Opioid Steering Committee to address the public opioid addiction crisis. This is an important step in the battle against opioid misuse, pain management and addiction.

We strongly support the FDA’s consideration of mandatory education for healthcare professionals on pain management, addiction and treatment. We believe these treatment practices and measures need further testing in real-world settings to ensure professionals are trained based on what the evidence has proven to work. This requires the FDA to take advantage of existing data sources and registry platforms to monitor opioid use and measure the impact of implementing best practices. We also encourage the FDA to ensure these approaches involve the patient as partners in their care to promote mutual understanding and expectations, increase compliance and decrease misuse.

There is much to be done. We look forward to working with the Committee to improve the way healthcare providers treat patients using more appropriate and safer pain management techniques.

-By Blair Childs, Premier, Senior Vice President of Public Affairs